Skip to main content

Advertisement

SpringerLink
Log in

TFF3 and survivin expressions associate with a lower survival rate in gastric cancer

  • Original Article
  • Published:
Clinical and Experimental Medicine Aims and scope Submit manuscript

Abstract

Trefoil factor 3 (TFF3) and survivin with functions of inhibiting apoptosis are involved in the gastric cancer by overexpression. The purpose of this study is to examine the expression of TFF3 and survivin in patients’ tissue samples with gastric cancer and analyze the relationship between the protein expression and the different clinical records. By studying the expressions of TFF3 and survivin in gastric cancer through immunohistochemical staining and examining the survival rate via Kaplan–Meier analysis for gastric cancer patients, we found that the TFF3 and survivin positive expressions have a significant relationship with the lower survival rate comparing to that of negative expressions in the analyzed patients (P < 0.05). And moreover, patients with double positive TFF3 and survivin expressions have the lowest survival rate. TFF3 or survivin positive expression correlates with the lymph node metastasis, metastasis, and TNM stages of gastric cancer. Survival analysis indicates that survival rate has a close relationship with the age, tumor histology, tumor differentiation, degree of infiltration, lymph node metastasis, distant metastasis, and TNM stages (P < 0.01). Our data suggest that TFF3 and survivin expressions play a vital role in gastric cancer development, and these two proteins are important markers for prognosis in gastric cancer. Patients with gastric cancer can increase the survival rate through an earlier diagnosis and appropriate treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Muskett FW, May FE, Westley BR, Feeney J (2003) Solution structure of the disulfide-linked dimer of human intestinal trefoil factor (TFF3): the intermolecular orientation and interactions are markedly different from those of other dimeric trefoil proteins. Biochemistry-Us 42:15139–15147

    Article  CAS  Google Scholar 

  2. Katoh M (2003) Trefoil factors and human gastric cancer (review). Int J Mol Med 12:3–9

    PubMed  CAS  Google Scholar 

  3. Liu D, Chinery R, Wilding J, Gullick WJ, Kmiot W, Pignatelli M (1997) Phosphorylation of γ-catenin and epidermal growth-factor receptor by intestinal trefoil factor. Lab Investig 77:557–563

    PubMed  CAS  Google Scholar 

  4. Efstathiou JA, Noda M, Rowan A, Dixon C, Chinery R, Jawhari A, Hattori T, Wright NA, Bodmer WF, Pignatelli M (1998) Intestinal trefoil factor controls the expression of the adenomatous polyposis coli-catenin and the E-cadherin-catenin complexes in human colon carcinoma cells. Proc Natl Acad Sci 95:3122–3127

    Article  PubMed  CAS  Google Scholar 

  5. Emami S, LeFloch N, Bruynell E, Thim L, May F, Westley B, Rio MC, Mareel M, Gespach C (2001) Induction of scattering and cellular invasion by trefoil peptides in src- and RhoA-transformed kidney and colonic epithelial cells. FASEB J 15:351–361

    Article  PubMed  CAS  Google Scholar 

  6. Taupin DR, Kinoshita K, Podolsky DK (2000) Intestinal trefoil factor confers colonic epithelial resistance to apoptosis. Proc Natl Acad Sci 97:799–804

    Article  PubMed  CAS  Google Scholar 

  7. Chen YH, Lu Y, DePlaen IG, Wang LY, Tan XD (2000) Transcription factor NF-kB signals antianoikic function of trefoil factor 3 on intestinal epithelial cells. Biochem Biophys Res Commun 274:576–582

    Article  PubMed  CAS  Google Scholar 

  8. Leung WK, Yu J, Chan FK, To KF, Chan MW, Ebert MP, Ng EK, Chung SC, Malfertheiner P, Sung JJ (2002) Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues. J Pathol 197:582–588

    Article  PubMed  CAS  Google Scholar 

  9. Yamachika T, Werther JL, Bodian C, Babyatsky M, Tatematsu M, Yamamura Y, Chen A, Itzkowitz S (2002) Intestinal trefoil factor: a marker of poor prognosis in gastric carcinoma. Clin Cancer Res 8:1092–1099

    PubMed  CAS  Google Scholar 

  10. Ahmed AR, Griffiths AB, Tilby MT, Westley BR, May FE (2012) TFF3 is a normal breast epithelial protein and is associated with differentiated phenotype in early breast cancer but predisposes to invasion and metastasis in advanced disease. Am J Pathol 180:904–916

    Article  PubMed  Google Scholar 

  11. Ambrosini G, Adida C, Altieri DC (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3:917–921

    Article  PubMed  CAS  Google Scholar 

  12. Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T, Reed JC (1998) IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 58:5315–5320

    PubMed  CAS  Google Scholar 

  13. Anti-Cancer AoC (1999) Diagnosis rules for new common malignant tumors. Peking Union Medicai College Press, Beijing

  14. Tang ZH, Chen HS, Zou ZK, Cai SB, Su HY, Shen HW, We WQ, Lin L, Wang YH (2008) Trefoil factor 4 and CD147 expression in carninogenesis of gastric mucosa and their correlation with angiogenesis. World Chin J Digestol 16:3631–3636

    CAS  Google Scholar 

  15. Kirikoshi H, Katoh M (2002) Expression of TFF1, TFF2 and TFF3 in gastric cancer. Int J Oncol 21:655–659

    PubMed  CAS  Google Scholar 

  16. Moss SF, Lee JW, Sabo E, Rubin AK, Rommel J, Westley BR, May FE, Gao J, Meitner PA, Tavares R, Resnick MB (2008) Decreased expression of gastrokine 1 and the trefoil factor interacting protein TFIZ1/GKN2 in gastric cancer: influence of tumor histology and relationship to prognosis. Clin Cancer Res 14:4161–4167

    Article  PubMed  CAS  Google Scholar 

  17. Rodrigues S, Van Aken E, Van Boxciaer S et al (2003) Trefoil peptides as proangiogenic factors in vivo and in vitro: implication of cyclooxygenase-2 and EGF receptor signaling. FASEB J 2003(17):7–16

    Article  Google Scholar 

  18. Dhar DK, Wang TC, Tabara H, Tonomoto Y, Maruyama R, Tachibana M, Kubota H, Nagasue N (2005) Expression of trefoil factor family members correlates with patient prognosis and neoangiogenesis. Clin Cancer Res 11:6472–6478

    Article  PubMed  CAS  Google Scholar 

  19. Guleng B, Han J, Yang JQ, Huang QW, Huang JK, Yang XN, Liu JJ, Ren JL (2012) TFF3 mediated induction of VEGF via hypoxia in human gastric cancer SGC-7901 cells. Mol Biol Rep 39:4127–4134

    Article  PubMed  CAS  Google Scholar 

  20. Yu J, Leung WK, Ebert MP, Ng EK, Go MY, Wang HB, Chung SC, Malfertheiner P, Sung JJ (2002) Increased expression of survivin in gastric cancer patients and in first degree relatives. Br J Cancer 87:91–97

    Article  PubMed  CAS  Google Scholar 

  21. Lee GH, Joo YE, Koh YS, Chung IJ, Park YK, Lee JH, Kim HS, Choi SK, Rew JS, Park CS, Kim SJ (2006) Expression of survivin in gastric cancer and its relationship with tumor angiogenesis. Eur J Gastroenterol Hepatol 18:957–963

    Article  PubMed  CAS  Google Scholar 

  22. Kania J, Konturek SJ, Marlicz K, Hahn EG, Konturek PC (2003) Expression of survivin and caspase-3 in gastric cancer. Dig Dis Sci 48:266–271

    Article  PubMed  CAS  Google Scholar 

  23. Lu CD, Altieri DC, Tanigawa N (1998) Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res 58:1808–1812

    PubMed  CAS  Google Scholar 

  24. Da CL, Xin Y, Zhao J, Luo XD (2009) Significance and relationship between Yes-associated protein and survivin expression in gastric carcinoma and precancerous lesions. World J Gastroenterol 15:4055

    Article  PubMed  CAS  Google Scholar 

  25. Bertazza L, Mocellin S, Marchet A, Pilati P, Gabrieli J, Scalerta R, Nitti D (2009) Survivin gene levels in the peripheral blood of patients with gastric cancer independently predict survival. J Transl Med 7:111

    Article  PubMed  Google Scholar 

  26. Kelly RJ, Lopez-Chavez A, Citrin D, Janik JE, Morris JC (2011) Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin. Mol Cancer 10:35

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This research was supported by the funding (Z07020) from the Bureau of Science and Technology of Zhangzhou City, China.

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Pathology, The NO. 175 Hospital of P.L.A., Zhangzhou, 363000, Fujian, China

    Jia-Rong Meng & He-Yi Guo

  2. Zhangzhou Health Vocation College, Zhangzhou, Fujian, China

    Hui-Zhong Tang

  3. Department of Pathology, Zhangzhou Hospital, Zhangzhou, Fujian, China

    Kai-Zong Zhou & Wu-Hong Shen

Authors
  1. Jia-Rong Meng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hui-Zhong Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kai-Zong Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wu-Hong Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. He-Yi Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jia-Rong Meng.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meng, JR., Tang, HZ., Zhou, KZ. et al. TFF3 and survivin expressions associate with a lower survival rate in gastric cancer. Clin Exp Med 13, 297–303 (2013). https://doi.org/10.1007/s10238-012-0210-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10238-012-0210-9

Keywords

Search

Navigation